. 2018 Jan 19;23(5):617–623. doi: 10.1634/theoncologist.2017-0457

Table 3. Subgroup analysis of cognitive functioning in survivors treated with chemotherapy containing ≥400 mg/m² of cisplatin versus controls.

Bolded values indicate significance.

Abbreviations: CHT ≥400, chemotherapy containing ≥400 mg/m² of cisplatin; CogOth, cognitive impairment perceived by others; CogPCI, perceived cognitive impairment; CogPCA, perceived cognitive abilities; CogQoL, quality of life affected by cognitive impairment; FACT‐Cog, Functional Assessment of Cancer Therapy‐Cognitive Function; OBS, observation (controls); SEM, standard error of the mean.

Table 3. Subgroup analysis of cognitive functioning in survivors treated with chemotherapy containing ≥400 mg/m2 of cisplatin versus controls.

Table 3. Subgroup analysis of cognitive functioning in survivors treated with chemotherapy containing ≥400 mg/m² of cisplatin versus controls.